Join
Live feed
·
NEWSReleasevia Quantisnow
Osmotica Pharmaceuticals plc logo

HC Wainwright & Co. Initiates Coverage On Osmotica Pharmaceuticals with Buy Rating, Announces Price Target of $5

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OSMT (Osmotica Pharmaceuticals plc) and more on Quantisnow.